HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic effects of an injectable new quinolone, pazufloxacin, against polymicrobial infections in the uterine endometritis model.

Abstract
Polymicrobial infections with aerobes and anaerobes are common in female genital tract infections. We evaluated the efficacy of an injectable new quinolon, pazufloxacin, using a uterine endometritis model. Rats were infected with a mixed inoculation of Escherichia coli plus Bacteriodes fragilis (MIC of pazufloxacin and ceftazidime: E. coli: 0.05 and 1.56 micrograms/ml, respectively, B. fragilis: 3.13 and 3.13 micrograms/ml, respectively). After inoculating 10(7) cfu/rat of each organism, pazufloxacin or ceftazidime (10 or 20 mg/kg, respectively, i.v., b.i.d., 3 days) was administered and compared with the nontreated group. The viable cell counts of the uterine corpus and uterine cervix in pazufloxacin-treated and ceftazidime-treated groups were decreased, compared with the nontreated group. The viable cell counts of the adnexa in the pazufloxacin-treated group were significantly decreased, compared with the ceftazidimetreated group. These results suggest that pazufloxacin would be useful for the treatment of polymicrobial infections, especially adnexitis.
AuthorsH Mikamo, K Kawazoe, Y Sato, T Tamaya
JournalChemotherapy (Chemotherapy) 1998 Mar-Apr Vol. 44 Issue 2 Pg. 99-102 ISSN: 0009-3157 [Print] Switzerland
PMID9551239 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Cephalosporins
  • Fluoroquinolones
  • Oxazines
  • pazufloxacin
  • Ceftazidime
Topics
  • Animals
  • Anti-Infective Agents (administration & dosage, therapeutic use)
  • Bacteroides Infections
  • Bacteroides fragilis (drug effects)
  • Ceftazidime (administration & dosage, therapeutic use)
  • Cephalosporins (administration & dosage, therapeutic use)
  • Colony Count, Microbial
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endometritis (drug therapy, microbiology)
  • Escherichia coli Infections
  • Female
  • Fluoroquinolones
  • Genital Diseases, Female (drug therapy, microbiology)
  • Injections, Intravenous
  • Microbial Sensitivity Tests
  • Oxazines (administration & dosage, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: